Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults

Published:2016-07-25 Issue:1 Volume:6 Page:44-53
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Townsend Robert¹,Dietz Albert²,Hale Christine³,Akhtar Shahzad¹,Kowalski Donna¹,Lademacher Christopher¹,Lasseter Kenneth⁴,Pearlman Helene¹,Rammelsberg Diane⁵,Schmitt-Hoffmann Anne⁶,Yamazaki Takao¹,Desai Amit¹

Affiliation:

1. Astellas Pharma Global Development, Inc; Northbrook IL USA

2. Spaulding Clinical Research, LLC; West Bend WI USA

3. Covance Clinical Research; Madison WI USA

4. Clinical Pharmacology of Miami, Inc; Miami FL USA

5. Randstad Pharma; Deerfield IL USA

6. Basilea Pharmaceutica International Ltd; Basel Switzerland

Funder

Astellas Pharma Global Development

Basilea Pharmaceutica International Ltd.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference19 articles.

1. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012;Azie;Diagn Microbiol Infect Dis,2012

2. Hidden killers: human fungal infections;Brown;Sci Transl Med,2012

3. Epidemiology of invasive fungal diseases on the basis of autopsy reports;Dignani;F1000 Prime Rep,2014

4. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial;Maertens;Lancet,2016

5. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis;Marty;Lancet Infect Dis,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism;BMC Cancer;2024-09-11

2. Drug–drug interactions in the management of non-tuberculous mycobacterial infections;Frontiers in Microbiology;2024-09-05

3. Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing;Journal of Antimicrobial Chemotherapy;2024-08-01

4. Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants;Antimicrobial Agents and Chemotherapy;2024-05-17

5. Pharmacological management of invasive mold infections in solid organ transplant recipients;Expert Opinion on Pharmacotherapy;2024-02-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3